MedTrace Logo

Drug Use Investigation for AVOLVE(BPH)

NCT01376284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2014-07-28

No results posted yet for this study

Summary

The study is designed to investigate the safety and efficacy of dutasteride capsules 0.5 mg collected from the required number of Japanese subjects with benign prostatic hyperplasia (BPH) in order to identify concerns or problems, if any, about the efficacy and safety of its use at post-marketing clinical settings.

Conditions

  • Prostatic Hyperplasia

Interventions

DRUG

Dutasteride

Collection of safety data

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
15 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2013-10-31
Completion
2014-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01376284 on ClinicalTrials.gov